This essay explores how ketamine operates as an anesthetic and as an antidepressant through separate but linked mechanisms. Drug repurposing is the application of a drug for a new medical use different from its original purpose, as indicated by the FDA. By comparison of peer-reviewed research on PubMed, NCBI, and clinical trials of ketamine's pharmacology, we find that the mechanism of its use...
This trial aims to provide Level I evidence comparing the respiratory depression risk between esketamine-based and fentanyl-based analgesia during HHNB-guided liver ablation. Should esketamine prove to be demonstrably superior in terms of respiratory safety, HHNB-esketamine has the potential to be a viable treatment option.
Psilocybin, a serotonergic psychedelic, is gaining attention for its rapid and sustained therapeutic effects in depression and other hard-to-treat neuropsychiatric conditions, potentially through its capacity to enhance neuronal plasticity. While its neuroplastic and therapeutic effects are commonly attributed to serotonin 2A (5-HT 2A ) receptor activation, emerging evidence reveals a more...
Introduction Aesthetic experiences under psychedelics are often described as vivid, emotionally powerful, and meaningful, yet they remain under-measured in psychometric research. This study aimed to refine and validate the Psychedelic Aesthetic Experience Questionnaire (PAEQ), a novel instrument designed to assess the aesthetic dimensions of acute psychedelic experiences. Methods A total of 365...
The serotonin 2C receptor (5-HT 2C ) is a G protein-coupled receptor implicated in multiple physiological and psychological processes and has been investigated as a therapeutic target for neuropsychiatric conditions such as obesity, drug abuse, and depression. With renewed interest in serotonergic psychedelics for treating depression, 5-HT 2C may contribute to psychedelic-induced therapeutic...
There is a lack of understanding of the nature of the post-acute affective response in the days after ecstasy/3,4-Methylenedioxymethamphetamine (MDMA) use and whether this is associated with ecstasy/MDMA use or circumstantial factors. In the three days following ecstasy/MDMA use, we evaluated whether a drop in mental well-being is observed and can be related to ecstasy use. Data for this study...
Classic psychedelics are increasingly studied as potential treatments for different psychiatric disorders. Current research protocols often require patients to discontinue antidepressants (ADs) for at least 2 weeks before psychedelic administration to decrease the risk of serotonin syndrome and limit their effect on efficacy and the acute subjective effects of psychedelics. Moreover, the...
Background: Evidence is growing that psychedelic substances have positive effects in the setting of Palliative Care (PC), focusing on special needs in this patient population. After a scoping review of the literature, no published expert recommendations guiding best practice for psychedelic-assisted therapy (PAT) towards the end of life were identified. Objective: To draw conclusions from...
Previous studies have examined how the COVID-19 pandemic affected dream recall, dream content, and nightmares. However, relatively little attention has been devoted to the individual and situational factors associated with pandemic-induced changes in dreams. The threat simulation theory of dreaming predicts that threatening situations in our waking life (situational factors) influence...
September 11, 2025Rakesh Kumar, Dushyant Kumar Singh
Electroencephalography-based emotion recognition remains an active research area. Unlike many existing pipelines that rely on large, redundant feature sets, we propose a streamlined yet robust framework to examine the influence of chanting the Hare Krishna mantra (HKM) and its musical rendition (Kirtan) on neuronal dynamics-a relatively unexplored direction. EEG signals were acquired using a...